Synthesis and in vitro binding studies of piperazine-alkyl-naphthamides: impact of homology and sulphonamide/carboxamide bioisosteric replacement on the affinity for 5-HT1A, alpha2A, D4.2, D3 and D2L receptors.

A series of carboxamide and sulphonamide alkyl(ethyl to hexyl)piperazine analogues were prepared and tested for their affinity to bind to a range of receptors potentially involved in psychiatric disorders. These chemical modifications led us to explore the impact of homology and bioisosteric replacement of the amide group. All of these compounds possessed a high affinity for 5-HT(1A) receptors, irrespective of the size of the linker, the carboxamide derivative with a pentyl linker had the highest affinity for alpha(2A) receptor sites and also a high affinity for 5-HT(1A) and D3 receptors. The sulphonamide analogue with a hexyl linker possessed a high affinity for 5-HT(1A), D4.2 and D3 receptors.

[1]  Jessica Sallander,et al.  Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity. , 2009, Journal of medicinal chemistry.

[2]  Bryan L. Roth,et al.  WAY-100635 is a potent dopamine D4 receptor agonist , 2006, Psychopharmacology.

[3]  H. Rhim,et al.  Preparation of piperazine derivatives as 5-HT7 receptor antagonists. , 2008, Bioorganic & medicinal chemistry.

[4]  B. Roth,et al.  Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia , 2004, Nature Reviews Drug Discovery.

[5]  L. Callado,et al.  Guanidine and 2-aminoimidazoline aromatic derivatives as alpha2-adrenoceptor ligands: searching for structure-activity relationships. , 2009, Journal of medicinal chemistry.

[6]  P. Sokoloff,et al.  N-(ω-(4-(2-Methoxyphenyl)piperazin-1-yl)alkyl)carboxamides as Dopamine D2 and D3 Receptor Ligands , 2003 .

[7]  B. Roth,et al.  Synthesis and in vitro binding studies of substituted piperidine naphthamides. Part I: Influence of the substitution on the basic nitrogen and the position of the amide on the affinity for D2L, D4.2, and 5-HT2A receptors. , 2007, Bioorganic & medicinal chemistry letters.

[8]  T. Svensson,et al.  Enhanced cortical dopamine output and antipsychotic-like effects of raclopride by alpha2 adrenoceptor blockade. , 1999, Science.

[9]  M. Kołaczkowski,et al.  The impact of spacer structure on 5-HT7 and 5-HT1A receptor affinity in the group of long-chain arylpiperazine ligands. , 2004, Bioorganic & medicinal chemistry letters.

[10]  C. Wermuth,et al.  Comprar The Practice of Medicinal Chemistry, 3rd Edition | Camille G. Wermuth | 9780123741943 | Academic Press , 2009 .

[11]  B. Everitt,et al.  Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist , 1999, Nature.

[12]  H. Meltzer,et al.  5‐HT2A and D2 receptor blockade increases cortical DA release via 5‐HT1A receptor activation: a possible mechanism of atypical antipsychotic‐induced cortical dopamine release , 2001, Journal of neurochemistry.

[13]  H. Rhim,et al.  Synthesis and biological evaluation of (phenylpiperazinyl-propyl)arylsulfonamides as selective 5-HT(2A) receptor antagonists. , 2010, Bioorganic & medicinal chemistry.

[14]  G. Dive,et al.  New Alkoxypyridine-sulfonamides: Synthesis, Biological Evaluation, and Physicochemical Properties , 1991 .

[15]  K. Wicke,et al.  The dopamine D3 receptor partial agonist, BP 897, is an antagonist at human dopamine D3 receptors and at rat somatodendritic dopamine D3 receptors. , 2001, European journal of pharmacology.

[16]  Michael Williams,et al.  Emerging opportunities for antipsychotic drug discovery in the postgenomic era. , 2008, Journal of medicinal chemistry.

[17]  Chemical Modifications on 4-Arylpiperazine-Ethyl Carboxamide Derivatives Differentially Modulate Affinity for 5-HT1A, D4.2, and α2A Receptors: Synthesis and In Vitro Radioligand Binding Studies , 2010 .

[18]  E. Novellino,et al.  Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors. , 2003, Journal of medicinal chemistry.

[19]  Synthesis and in vitro binding studies of substituted piperidine naphthamides. Part II: Influence of the substitution on the benzyl moiety on the affinity for D2L, D4.2, and 5-HT2A receptors. , 2007, Bioorganic & medicinal chemistry letters.